Kristina Johnson

A DNA sequence exploring lung cancer and their hereditary genes.

Is Lung Cancer Hereditary?

By Kristina Johnson |

Some forms of lung cancers can be connected to hereditary factors. Non-small cell lung cancers have a higher chance of being hereditary or connected to gene mutations.

Read More

A girl asking her specialist questions about mesothelioma. They are sitting across from each other at a desk.

Top 5 Questions About Mesothelioma

By Kristina Johnson |

Getting diagnosed with mesothelioma is intimidating, but here are five questions to ask you specialist to ease any fears. The more information you know about mesothelioma and your treatment, the easier this process will be.

Read More

Chemo brain patient practicing yoga.

5 Helpful Tips for Chemo Brain

By Kristina Johnson |

Chemo brain slows the brain's cognitive function throughout chemotherapy treatments. Many patients compare this to having a mental fog. Learn how to help your chemo brain symptoms here.

Read More

White blonde mature woman sitting on floor with couch and plant in the background practicing breathing exercises for lung health

5 Breathing Exercises for Lungs

By Kristina Johnson |

Five breathing exercises for lungs - tips for lung cancer and mesothelioma patients to help improve breathing and overall lung health.

Read More

Doctor looking at mesothelioma patient's lung x-rays

Healthy Lung Tips After Cancer Diagnosis

By Kristina Johnson |

Person in hazmat suit being protected by harmful VOCs which surround them.

Lung Cancer Detection Tests for Volatile Organic Compounds (VOCs)

By Kristina Johnson |

A new study by researchers at the University of Louisville has shown promising results for diagnosing lung cancer by testing breath samples for volatile organic compounds (VOCs). The study has shown seven VOCs that are common in patients with lung cancer.

Read More

Adagrasib alongside a needle, pills, and vials scattered on white table

Mirati’s Adagrasib Non-Small Cell Lung Cancer Treatment Approved

By Kristina Johnson |

Adagrasib is the newest inhibitor drug for the treatment of KRAS-G12C mutated non-small cell lung cancer has been approved by the FDA. Mirati Therapeutics brings adagrasib to the market as an oral drug to help late-stage NSCLC patient's prognosis.

Read More